Lilly, AdvanCell to collaborate on alpha treatments for cancer
by
Contributor since / Followers
Contributor since / Followers
2 months ago
jetcityimage
- Eli Lilly (NYSE:LLY) and AdvanCell have agreed to work together on developing alpha therapies for the treatment of cancer.
- AdvanCell, which is based in Australia, uses a technology known as an alpha isotope generator “which addresses the greatest unmet need in targeted alpha